REG - Malin Corp PLC - Notice of 2022 Interim Results

MalinAnnouncement

25/08/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220825:nRSY1253Xa&default-theme=true

RNS Number : 1253X  Malin Corporation PLC  25 August 2022

Malin Corporation plc

 

Notice of 2022 Interim Results

 

Dublin-Ireland, 25 August 2022: Malin Corporation plc. (Euronext Growth
Dublin:MLC) ("Malin" or "the Company"), a company investing in highly
innovative life sciences companies, intends to announce its interim financial
results and publish its interim report for the six month period ended 30 June
2022 at 07:00am Irish Standard Time / BST on Wednesday, 7 September 2022.

 

Darragh Lyons, Chief Executive Officer, will host a conference call at 12:00pm
Irish Standard Time / BST on the day of publication. This call can be accessed
as follows:

 

From Ireland dial:                             01
53695 84

From the UK dial:
020 3936 2999

From the USA dial:                            1 646
664 1960

From all other locations dial:          +44 203 936 2999

Participant access code:               978118

 

The Company's results press release and presentation will be available on the
Company's website from 07:00am Irish Standard Time / BST on 7 September 2022
at www.malinplc.com (http://www.malinplc.com) .

 

 

ENDS

 

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative
life sciences companies. Its purpose is to create shareholder value through
the application of long-term capital and operational and strategic expertise
to a diverse range of global healthcare businesses. Malin has a focus on
innovative businesses underpinned by exceptional science and works with its
investee companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and domiciled in
Ireland and listed on the Euronext Growth Dublin. For more information
visit www.malinplc.com (http://www.malinplc.com/)

For further information contact:

ENDS

 

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative
life sciences companies. Its purpose is to create shareholder value through
the application of long-term capital and operational and strategic expertise
to a diverse range of global healthcare businesses. Malin has a focus on
innovative businesses underpinned by exceptional science and works with its
investee companies, providing strategic and financial support to enable them
to reach their value potential. Malin is headquartered and domiciled in
Ireland and listed on the Euronext Growth Dublin. For more information
visit www.malinplc.com (http://www.malinplc.com/)

For further information please contact:

 

Malin

Fiona Dunlevy, Company Secretary

Tel: +353 (0)1 901 5700

investorrelations@malinplc.com (mailto:investorrelations@malinplc.com)

 

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

 

Liberum (Joint Broker)

Phil Walker / Ben Cryer

Tel: +44 (0) 20 3100 2000

 

Powerscourt (Media enquiries)

Eavan Gannon

Tel: +353 87 236 5973

malin@powerscourt-group.com (mailto:malin@powerscourt-group.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFLFFETRISFIF